0000950170-24-094967.txt : 20240809 0000950170-24-094967.hdr.sgml : 20240809 20240809192721 ACCESSION NUMBER: 0000950170-24-094967 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240809 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobson Mark L. CENTRAL INDEX KEY: 0001805812 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 241194363 MAIL ADDRESS: STREET 1: 200 BROADWAY STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10038 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 ownership.xml 4 X0508 4 2024-08-09 0001579428 Axsome Therapeutics, Inc. AXSM 0001805812 Jacobson Mark L. C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 false true false false Chief Operating Officer true Common Stock 2024-08-09 4 M false 47739 4.04 A 53522 D Common Stock 2024-08-09 4 S false 47739 84.26 D 5783 D Stock Option (Right to Buy) 4.04 2024-08-09 4 M false 47739 0.00 D 2015-12-29 2024-12-29 Common Stock 47739 0 D Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this year. Such transaction was pursuant to a pre-approved 10b5-1 plan. Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $82.705 and $85.975. /s/ Mark Jacobson 2024-08-09